Hand Held Nitrous Oxide Delivery Device
HHN
Safety and Efficacy of Hand Held Nitrous, a Device That Delivers 16 Grams of Nitrous Oxide Over 120 Seconds of Inhalation Time.
1 other identifier
interventional
250
1 country
2
Brief Summary
To study the safety and efficacy of Hand Held Nitrous. A device that delivers 120 seconds of up to 72% nitrous oxide and ambient air.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2013
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 11, 2014
CompletedFirst Posted
Study publicly available on registry
April 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedApril 21, 2014
April 1, 2014
1.4 years
April 11, 2014
April 17, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
This study measures the types of complications (if any) associated with the use of small set amount of nitrous oxide.
This is a short acting device that delivers a small amount of nitrous oxide. The patient responds quickly and recovers quickly (approximately 6 minutes).
The patient is under observation for the length of the procedure or until baseline parameters are met (under 10 minutes). No followup is required.
Study Arms (1)
Hand Held NitrousTM
EXPERIMENTALThere are no other interventions to this device
Interventions
This device gives patients the opportunity to receive nitrous oxide where no such opportunity exists. There is no other intervention available that creates immediate short term minimal sedation.
Eligibility Criteria
You may qualify if:
- Any patient undergoing a painful office procedure or exam
You may not qualify if:
- Women that are Pregnant
- Children under three years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Lubbock Urology
Lubbock, Texas, 79423, United States
Other Medical Practices
Lubbock, Texas, 79423, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Howard Beck, MD
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- President
Study Record Dates
First Submitted
April 11, 2014
First Posted
April 21, 2014
Study Start
July 1, 2013
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
April 21, 2014
Record last verified: 2014-04